Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-94.47M
Cash
193.4M
Avg Qtr Burn
-2.747M
Short % of Float
14.20%
Insider Ownership
10.18%
Institutional Own.
86.56%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Budoprutug Details Kidney disease, Primary Membranous Nephropathy | Phase 1b Update | |
ETX-123 (Kv7.2/3 channel opener) Details Epilepsy, Seizures, Pain | Failed Discontinued | |
ETX-155 Details Major depressive disorder, Perimenopausal Depression | Failed Discontinued | |
ETX-810 Details Chronic pain, Sciatica , Pain, Diabetes | Failed Discontinued | |
ETX-155 Details Epilepsy | Failed Discontinued | |
ETX-810 Details Chronic pain, Pain, Sciatica | Failed Discontinued |